1214377-46-4 Usage
Description
3-bromo-4-(difluoromethoxy)pyridine is a pyridine derivative with the molecular formula C6H4BrF2NO. It is an organic compound characterized by a pyridine ring with a bromine atom at the third position and a difluoromethoxy group at the fourth position. 3-bromo-4-(difluoromethoxy)pyridine is utilized in organic synthesis and has potential applications in the pharmaceutical and agrochemical industries.
Uses
Used in Pharmaceutical Industry:
3-bromo-4-(difluoromethoxy)pyridine is used as a building block for the synthesis of biologically active molecules. Its unique structure allows for the creation of various compounds with potential therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical industry, 3-bromo-4-(difluoromethoxy)pyridine serves as a precursor for the development of new agrochemicals, contributing to the synthesis of molecules with pesticidal or herbicidal activities.
Used in Organic Chemistry as a Reagent:
3-bromo-4-(difluoromethoxy)pyridine is employed as a reagent for creating carbon-carbon and carbon-heteroatom bonds. Its presence facilitates the formation of these bonds, which are crucial in the synthesis of complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 1214377-46-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,4,3,7 and 7 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1214377-46:
(9*1)+(8*2)+(7*1)+(6*4)+(5*3)+(4*7)+(3*7)+(2*4)+(1*6)=134
134 % 10 = 4
So 1214377-46-4 is a valid CAS Registry Number.
1214377-46-4Relevant articles and documents
PYRIDINYL PYRAZOLES AS MODULATORS OF RORyT
-
Paragraph 0387, (2020/01/08)
The present invention comprises compounds of Formula I. wherein: R1, R3, R4, R5, R6, and Q are defined in the specification. The invention also comprises a method of treating or ameliorating a ROR-γ-t mediated syndrome, disorder or disease, including wherein the syndrome, disorder or disease is selected from the group consisting of rheumatoid arthritis, psoriatic arthritis, and psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of Formula I.
ALDOSTERONE SYNTHASE INHIBITORS
-
, (2012/11/13)
This invention relates to tricyclic triazole analogues of the formula I or their pharmaceutically acceptable salts, wherein the variable are defined herein. The inventive compounds selectively inhibit aldosterone synthetase. This invention also provides for pharmaceutical compositions comprising the compounds of Formula I or their salts as well as to methods for the treatment, amelioration or prevention of conditions that could be treated by inhibiting aldosterone synthetase.
